Skip to content
thispeptide

Rewinding RX

A founder-led longevity shop that prices NAD+, semaglutide and tirzepatide the same at every dose. It never names a doctor, a medical group or a pharmacy.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Rewinding RX is easy to price and hard to see behind. You get one figure per product, at any dose. Several pages say you are charged only after a doctor approves you. You never learn who that doctor is. The site also gives two different answers on whether nurses review cases.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Lowest listed: Semaglutide injection, from $139/mo

All 50 states

Visit Rewinding RX →

Rewinding RX is a cash-pay telehealth shop run by Rewinding RX LLC in Boca Raton, Florida. Its founder, Mark Seremet, co-founded the video game publisher Take-Two Interactive. He tells his own health story on several pages. The shop sells NAD+, semaglutide and tirzepatide, plus a wider peptide shelf. It also sells supplements, skin creams and a coaching plan called The Rewinding Method.

What Rewinding RX prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $139/mo
    • Sublingual (compounded)From $139/mo
  • TirzepatideFDA-approved
    • Injection (compounded)From $189/mo
    • Sublingual (compounded)From $169/mo

Semaglutide is $139 a month and tirzepatide $189, the same at every dose. The weight page prints each ladder, from 0.25 mg to 2.5 mg and 2.125 mg to 14.5 mg. It gives no schedule. Both are compounded with glycine and vitamin B12. Sublingual drops cost $139 and $169, with no dose printed. Separate microdose programs cost $119 and $169 a month.

Sexual health

PT-141 is $239 on subscription or $249 bought once. You get a 5 mL vial at 2 mg per mL. The page does not say how long a vial lasts or how often you inject.

Longevity

  • NAD+Legal to compound
    • Injection (compounded)From $139/mo

NAD+ is $139 a month on subscription or $149 for one month. You get a 5 mL vial holding 1,000 mg, at 200 mg per mL. The FAQ says to start at 20 mg and work up to 100 mg, one to three times a week. The page also says NAD+ must be taken with the shop's own supplement, or TMG, for best results.

Recovery

  • SermorelinLegal to compound
    • Injection (compounded)Price not published

Sermorelin is $189, injected under the skin and typically dosed at night. The page prints no vial size and no period for the price. It also says plainly that sermorelin is not FDA approved.

Sleep

  • SermorelinLegal to compound
    • Injection (compounded)Price not published

Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.

Who prescribes

A licensed clinician

The site names no doctor, no medical group and no pharmacy. Its footer says independent licensed physicians prescribe. The terms say Rewinding RX is not a medical group and does not practice medicine. They refer to Medical Groups and Providers without naming any of them. The counts are specific even though the names are not. The about page says 85 licensed, specialized physicians, never nurses or physician assistants. The homepage repeats that every case is reviewed by a fully licensed MD. Its own FAQ then says the network includes nurse practitioners, dermatologists and pharmacists. Pharmacies are described only as US 503A compounding pharmacies. The footer carries a LegitScript seal for the site.

You pick a product, check out online and then answer a medical questionnaire. A physician reviews it, within 24 hours on the NAD+ page and 24 to 48 hours on product pages. A video or phone visit is not mentioned anywhere. The NAD+ and microdose pages say you are charged only if a doctor approves you. NAD+ ships within 72 hours. After that, the weight FAQ promises unlimited access to your physician. On the weight program, your care team adjusts the dose as you go. Clinician messaging is listed as part of the price. The weight page promises nutrition and movement support too, but says you will hear about it after you enroll.

Are labs required?

Not mentioned

No page mentions bloodwork, before or during treatment. The terms list labs among the outside parties involved, with no price and no requirement.

Ready to start with Rewinding RX?

Lowest listed price: Semaglutide injection, from $139/mo. Confirm it on the seller’s own site.

Visit Rewinding RX →

What it claims, and what it cites

The weight page says semaglutide users lost 15% of body weight on average in clinical trials, and tirzepatide users 20%. No trial is named. Those trials tested the brand-name drugs, not compounded versions with added glycine and B12. The peptide pages are more careful. BPC-157 is called a promising research peptide rather than a proven treatment, and MOTS-C evidence is called mostly preclinical. The microdose page cites one 2023 paper on GLP-1 drugs and cognitive function. The founder's own story carries the rest.

On Rewinding RX’s siteSource it gives
On Rewinding RX’s site“Average 15% body weight lost in clinical trials”Source it givesNone given
On Rewinding RX’s site“Average 20% body weight lost - strongest result available”Source it givesNone given
On Rewinding RX’s site“Over a million consultations performed by our Telehealth physicians”Source it givesNone given
On Rewinding RX’s site“For optimal results NAD+ must be taken with Rewind Time”Source it givesNone given

Sold by Rewinding RX, not listed here

Tesamorelin
Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
BPC-157
On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
TB-500
On no FDA compounding list: absent from the 503A categories (updated May 14, 2026) and the 503B categories (updated March 21, 2025). FDA's compounding advisory committee voted 8-6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
MOTS-c
On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
Tesamorelin
Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
BPC-157
On no 503A list (removed from Category 2 in April 2026, never in Category 1). The FDA's compounding advisory committee voted 8–6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
BPC-157 with TB-500
On no FDA compounding list: absent from the 503A categories (updated May 14, 2026) and the 503B categories (updated March 21, 2025). FDA's compounding advisory committee voted 8-6 (one abstention) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
MOTS-C
On no 503A list (not in Categories 1–3 of the May 14, 2026 update). The FDA's compounding advisory committee voted 7–5 (two abstentions) in July 2026 to favor listing it; the vote is a recommendation, not binding on the FDA, and pharmacies may not compound it until final rulemaking.
Semax
On no FDA compounding list. Semax appears in neither the 503A bulk drug substances categories (updated May 14, 2026) nor the 503B categories (updated March 21, 2025).
Selank
On no FDA compounding list. Selank appears in neither the 503A bulk drug substances categories (updated May 14, 2026) nor the 503B categories (updated March 21, 2025).
Microdose semaglutide and tirzepatide
Separate low-dose programs, not comparable with full-dose prices.
Tirzepatide with NAD+
A combination product, priced at $199 with no dose printed.
LIPO-B, supplements and skin creams
Vitamin and topical products, not peptides this site covers.

How it bills

Each product has one price at every dose. You pay nothing extra for the doctor, messaging or shipping. Some products also offer a one-time purchase for $10 to $20 more. Canceling is the hard part. The site says cancel anytime. The terms say you must cancel at least ten days before renewal, or the next period is charged. Shipments can be charged up to five days early. The terms list an email address, account messaging and a phone number printed as hash marks. Part-used periods are not refunded, and prescription returns are refused. A defective order is replaced if you report it within 7 days.

Availability: All 50 states

LegitScript: seal displayed on the seller’s site

For and against

  • For: One price at every dose
  • For: No charge until a doctor approves you
  • For: NAD+ strength and starting dose printed
  • For: Unlimited physician access promised
  • Against: No doctor, group or pharmacy named
  • Against: Conflicting answers on who reviews cases
  • Against: Ten-day cancel deadline in the terms only
  • Against: Phone number printed as hash marks
  • Against: Weight-loss averages cite no trial

The evidence behind what it sells

Right for

Someone who wants one fixed NAD+ or GLP-1 price at any dose and does not need to know their prescriber.

Look elsewhere if

Anyone who wants a named doctor, a video visit or a pharmacy they can look up.

Other sellers for weight

Rewinding RX

Frequently asked questions

Who prescribes at Rewinding RX?
Independent licensed physicians, per the site. It names none of them and no medical group. The about page says 85 physicians and no nurses, but the homepage FAQ lists nurse practitioners too.
Does the Rewinding RX price rise with the dose?
No. Semaglutide is $139 a month and tirzepatide $189 at every dose. NAD+ is $139 a month on subscription.
What is in the Rewinding RX semaglutide?
Compounded semaglutide with glycine and methylcobalamin, a form of vitamin B12. Tirzepatide comes with the same two additions.
How do I cancel Rewinding RX?
By email or account message at least ten days before renewal. The terms also list a phone line, but print the number as hash marks.

See what Rewinding RX prescribes today

Rewinding RX sets its own prices, plans and the states it serves. Check them before you start.

Visit Rewinding RX →
Written by Molly Ward from Rewinding RX’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.